Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
accumulated, CEO, coverage, escrow, FINRA, forward, Hospital, leukemia, lt, moved, OTC, OTCQB, owed, quotation, regressed, shown, site, thirteen, vendor
Removed:
Additionally, AICPA, allocated, allocating, cGMP, consideration, cumulative, determination, disclose, disclosing, EITF, entity, evaluate, evaluating, FASB, Food, guidance, implementation, longer, monitoring, multiple, permitting, pharmacology, recognition, residual, SEC, separately, standard, toxicity, toxicology, trading, update, updated
Filing tables
Filing exhibits
IPIX similar filings
Filing view
External links
Exhibit 10-35
ADDENDUM TO EHRLICH DEMAND UNSECURED NOTE
KNOWN AS EHRLICH PROMISSORY NOTE C
IN THE AMOUNT OF $1,750,000.00
DATED AUGUST 25, 2010
Today April 1, 2011, Cellceutix Corporation (“Cellceutix”) and Leo Ehrlich agree to amend the Ehrlich Promissory Note C as follows:
1. | The limit on the note is herewith changed to $2,000,000. |
2. | Cellceutix agrees to convert accrued interest of $96,677 through December 31, 2010 into principal. This will result in the Ehrlich Promissory Note having a principal balance of $1,672,264 as of January 1, 2011. |
3. | All other terms remain and are not changed. |
_____/s/ Leo Ehrlich
Leo Ehrlich
______/s/Krishna Menon
Krishna Menon